INTRODUCTION
============

The stimulation of sensory systems plays essential roles in neuronal functions including information processing, dendritic and axonal refinement, synaptic plasticity, and survival of sensory neurons ([@b5-molce-38-6-535]; [@b11-molce-38-6-535]; [@b18-molce-38-6-535])., Sensory neuronal activation is especially critical for neuronal survival. The results of several studies have suggested that sensory deprivation impaired the survival of sensory neurons. In many cases, diminished sensory capacity due to aging, injuries, or neurodegenerative diseases leads to the death of sensory neurons ([@b1-molce-38-6-535]; [@b19-molce-38-6-535]). However, the processes and mechanisms involved in activity-dependent sensory neuronal survival have yet to be fully elucidated.

The phosphatidylinositol 3′-kinase (PI3K)/Akt pathway, which is activated by the generation of 3′-phosphorylated phosphoinositides, has been implicated as an important signaling pathway for survival in a wide variety of cell types \[see review ([@b3-molce-38-6-535])\]. Moreover, increasing evidence suggests that the activation of different intracellular survival pathways, including the PI3K/Akt pathway, is regulated by variety of cellular activities ([@b7-molce-38-6-535]; [@b9-molce-38-6-535]; [@b26-molce-38-6-535]). In some cases, the prevention of neuronal cell death requires *de novo* gene expression, suggesting that some components or regulators of the anti-apoptotic machineries need to be newly synthesized before apoptosis occurs. For instance, Bcl-2, a critical component of the anti-apoptotic machineries, is up-regulated during the apoptosis of neurons \[see review ([@b14-molce-38-6-535])\]. Additionally, decreased Bcl-2 expression induces apoptosis by activating pro-apoptotic molecules, such as BAX and BAD, whereas Bcl-2 over-expression prevents cell death by inhibiting the apoptosis cascade \[see review ([@b6-molce-38-6-535]; [@b29-molce-38-6-535])\].

The mammalian olfactory system is an advantageous experimental model for studying the processes and mechanisms of activity-dependent cellular responses due to its cytoarchitecture, life cycle, and availability of *in vivo* and *in vitro* models ([@b15-molce-38-6-535]). Odorant stimulation induces activation of various signaling cascades in olfactory receptor neurons (ORNs). In our previous study, deprivation of odorant stimulation through unilateral naris occlusion caused an up-regulation of apoptosis in olfactory epithelium (OE) neurons ([@b21-molce-38-6-535]). Additionally, odorant stimulation enhances olfactory neuronal survival by activating the MAPK pathway, possibly resulting in Bcl-2 expression in ORNs ([@b27-molce-38-6-535]; [@b28-molce-38-6-535]). Although odorant stimulation appears to be involved in ORN survival, the underlying mechanisms remain unclear. In our present study, we investigated the ability of odorant stimulation to activate the PI3K/Akt pathway, induce subsequent Bcl-2 expression, and promote ORN survival using the olfactory system as a model.

MATERIALS AND METHODS
=====================

Animals
-------

All experimental protocols were approved by the Institutional Animal Care and Use Committees of both DGIST and The Johns Hopkins University, and all applicable guidelines for the care and use of laboratory animals from the National Institutes of Health Guide were followed. Adult male mice (C57/BL6, 6--7 weeks old) and rat pups (Sprague Dawley, days 1--2 postpartum) were obtained from Harlan (USA) and KOATECH (Korea).

Cell viability assay
--------------------

Cell viability was monitored by the calcein assay, which examined cells stained with calcein acetoxymethylester (AM) (C3100MP, Invitrogen, USA). Cultured ORNs were treated with a 10 μM odorant mixture for 6 h and 18 h, respectively, prior to incubation with calcein AM solution (final concentration 3 μM) for 30 min. Cell viability was measured at wavelengths of 485 nm (excitation) and 535 nm (emission) using a microplate reader (SpectraMax Plus 384 Microplate Reader, Molecular devices, USA).

Immunoblot analysis
-------------------

Immunoblots were performed according to methods of [@b12-molce-38-6-535] and [@b23-molce-38-6-535] with some modifications. ORN extracts were solubilized in boiling sample buffer (100 mM Tris-HCl, 2% sodium dodecyl sulfate \[SDS\], 10% β-mercaptoethanol, and 20% glycerol; pH 6.8) and fractionated by SDS-polyacrylamide gel electrophoresis (10% polyacrylamide). The proteins were transferred onto polyvinylidene difluoride membranes, which were incubated with primary antibodies overnight at 4°C, followed by secondary antibody for one hr at room temperature. Immunoreactivity was detected using chemiluminescence reagents (ECL, Amersham, USA) and visualized after exposure to X-Omat film (Kodak).

*In situ* hybridization
-----------------------

*In situ* hybridization was performed as previously described with some modifications ([@b22-molce-38-6-535]). Digoxigenin (DIG)-labeled probes were used from identified clones. Bouin's fixed tissue sections of rat OE (18 μm) were permeabilized with 1 μg/ml Proteinase K (Boehringer Mannheim, USA) for 30 min at 37°C in Tris-*buffered* saline (TBS) containing 2 mM CaCl2 and post-fixed in Bouin's for 5 min at room temperature. After prehybridization at 37°C for 10 min with 2 X saline-sodium citrate (SSC) containing 50% (v/v) deionized formamide, sections were hybridized overnight at 65--72°C with prepared RNA probe in 50--100 μl of hybridization buffer (50% deionized formamide, 10% dextran sulfate, 2× SSC, 0.02% SDS, and 0.01% sheared salmon sperm DNA). On the following day, post-hybridization was carried out by immersion in 2× SSC, washing with SSC, and digestion of the single-stranded RNA probe by RNase A (20 μg/ml) for 30 min at 37°C in TNE buffer (10 mM Tris, 500 mM NaCl, 5 mM EDTA; pH 7.5). To visualize bound probe, sections were incubated with an anti-DIG Fab fragment (Boehringer Mannheim, USA) in TBS containing 10% fetal calf serum for one h after being blocked with 10% fetal calf serum in TBS for 15 min. Sections were then washed twice in TBS and incubated for 5 min in *alkaline phosphatase (*AP) buffer (0.1 M Tris-Cl, 0.1 M NaCl, 50 mM MgCl~2~; pH 9.5). The color signal was developed in AP buffer containing 3.375 mg/ml *nitro blue tetrazolium* (Boehringer Mannheim, USA), 3.5 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (Boehringer Mannheim, USA), and 0.24 mg/ml levamisole. The colorimetric reaction was carried out at room temperature and terminated by washing with dH2O. The developed slides were coverslipped with Aquapolymount (Polysciences, USA). As a control experiment, sections are hybridized with identical amounts of sense cRNA.

Northern blot
-------------

For Northern blot analysis, total RNA was purified from ORNs with TRIzol reagent (Gibco-BRL, USA) as previously described with some modifications ([@b22-molce-38-6-535]). Total RNA was loaded and electrophoresed in 1% agarose/2.2 M formaldehyde denaturing gel. The RNAs were transferred onto Hybond N+ nitrocellulose membranes (Amersham Pharmacia Biotech, USA) using 10 × SSC and cross-linked using a UV cross-linker (Stratagene, USA). Hybridization of the membranes was carried out with ^32^P-labeled cDNA probes under 5× SSC, 5× Denhardt's solution, 1% SDS, and 100 μg/ml denatured salmon sperm DNA. Membranes were then washed twice in 2× SSC/0.1% SDS at 25°C, 0.2× SSC/0.1% SDS at 42°C, and 0.1 × SSC/0.1% SDS at 68°C. Signals from the hybridized probe cDNAs were visualized by exposure to X-ray film.

Primary culture of ORNs
-----------------------

Primary cultures of ORNs were performed as previously described ([@b16-molce-38-6-535]; [@b17-molce-38-6-535]) with some modifications. Culture dishes (Falcon, USA) were coated with modified Eagle's medium containing D-valine (MDV, Gibco-BRL, USA) and 25 μg/ml laminin (Collaborative Research, USA). ORNs were plated at a density of 6 × 10^5^ cells/cm^2^, and then fed with MDV containing 15% dialyzed fetal calf serum (Gibco-BRL, USA), gentamycin, kanamycin, and 25 ng/ml nerve growth factor (NGF) on each day. The concentration of NGF in the feeding medium was changed to 2.5 ng/mL two days prior to use.

Pharmacological manipulation of signaling cascades
--------------------------------------------------

LY294002 (Invitrogen, USA), a PI3K specific-inhibitor, in dimethyl sulfoxide stock was used in this study. Following pre-incubation in medium containing LY294002 at the final concentration of 50 μM for 30 min, ORNs were incubated for designated durations.

Unilateral naris occlusion
--------------------------

Unilateral sensory deprivation was performed following the method of Cummings with modification ([@b4-molce-38-6-535]; [@b21-molce-38-6-535]). Constructed nasal tubes (PE50, 0.965 mm outer diameter, Becton Dickinson, USA) were inserted into the right nostrils of male adult C57BL/6J mice (8 weeks old) from Jackson Laboratories (USA) under anesthesia using Xylaket. After recovering from the anesthetic, mice were raised under normal conditions until being sacrificed.

RESULTS
=======

Odorant stimulation induces the anti-apoptotic protein Bcl-2
------------------------------------------------------------

Bcl-2 is a well-established anti-apoptotic protein known to promote neuronal survival ([@b14-molce-38-6-535]; [@b29-molce-38-6-535]). We previously showed that Bcl-2 induced by leukemia inhibitory factor acted as an anti-apoptotic protein and promoted olfactory neuronal survival ([@b13-molce-38-6-535]). Because odorant stimulation appears to promote ORN survival ([@b27-molce-38-6-535]), we examined whether odorant stimulation affected the expression of Bcl-2 in a manner that would facilitate olfactory neuronal survival. Mice with unilateral naris occlusions and subsequent olfactory stimulus deprivation were exposed to a 1 mM odorant mixture (2-isobutyl-3-methoxypyrazine, citralva, and isovaleric acid) for 6 h. Then, the OE of the mice was examined using an *in situ* hybridization analysis. In the OE, *bcl-2* mRNA was present in most mature layers, which correlated well with *omp* mRNA-expressing layers, but not in the basal cell layer ([Fig. 1A](#f1-molce-38-6-535){ref-type="fig"}). The open side displayed a clear increase in *bcl-2* mRNA expression in the OE, suggesting that odorant stimulation may induce *bcl-2* mRNA expression. In order to examine the Bcl-2 expression attributable to odorant stimulation in ORNs, we examined Bcl-2 expression in dissociated cultures of ORNs under odorant exposure conditions. Northern blot analysis revealed that *bcl-2* mRNA expression was clearly increased after treatment with vehicle and odorant mixtures at 10 μM for 6 h ([Fig. 1B](#f1-molce-38-6-535){ref-type="fig"}). We also confirmed an increase in Bcl-2 protein levels in a time dependent manner under the same conditions ([Fig. 1C](#f1-molce-38-6-535){ref-type="fig"}). After 12 h of treatment, odorants induced significant up-regulation of Bcl-2 without changes in *neuron-specific tubulin* (NST) expression levels, indicating that there was no increase in number of neurons ([Fig. 1C](#f1-molce-38-6-535){ref-type="fig"}). Based on our *in vivo* and *in vitro* experiments, we suggest that odorant stimulation increases the expression of *Bcl-2* mRNA and protein levels after 12 h of exposure to odorant stimulation.

Odorant stimulation activates the PI3K/Akt pathway and promotes PI3K/Akt pathway-dependent Bcl-2 expression
-----------------------------------------------------------------------------------------------------------

To investigate additional mechanisms of Bcl-2 expression in the response to sensory stimuli, we focused on an examination of the activation of the PI3K/Akt pathway by odorant stimulation ([@b20-molce-38-6-535]; [@b24-molce-38-6-535]; [@b25-molce-38-6-535]). To explore the activation of the PI3K/Akt pathway by odorant stimulation, we investigated an aspect of the downstream activation of the PI3K/Akt pathway, a serine/threonine protein kinase Akt (protein kinase B). Strikingly, odorant stimulation induced transient activation of Akt at very early time points (1.5--3 h; [Fig. 2A](#f2-molce-38-6-535){ref-type="fig"}).

To examine the relationship between Akt and Bcl-2 expression in ORNs, we blocked the activation of the PI3K/Akt pathway by either preincubating with LY294002 (50 μM), a specific inhibitor of PI3K, or knocking-down Akt expression using a small interfering RNA (siRNA) for Akt1, which is a major component of Akt (data not shown). PI3K inhibition using LY294002 blocked odorant stimulation-promoting Bcl-2 induction, implying that odorant stimulation-induced Bcl-2 expression may be regulated by the PI3K/Akt pathway ([Fig. 2B](#f2-molce-38-6-535){ref-type="fig"}). Additionally, inhibition of Akt1 expression using Akt1 siRNA also blocked the odorant stimulation-promoting Bcl-2 induction, indicating that odorant stimulation-induced Bcl-2 expression is regulated by Akt1 ([Fig. 2C](#f2-molce-38-6-535){ref-type="fig"}). Although a temporal difference in the activation of Akt and the expression of Bcl-2 was observed, Akt activation and Bcl-2 expression by odorant stimulation may be deeply connected.

Odorant stimulation promotes long-term ORN survival via the PI3K/Akt pathway
----------------------------------------------------------------------------

Next, we examined whether the PI3K/Akt pathway activated by odorant stimulation would affect ORN survival by using dissociated cultures of ORNs. To detect a correlation between the activation of the PI3K/Akt pathway and Bcl-2 expression in ORN survival, we examined cell viability during the 6 h that represented PI3K/Akt pathway activation without Bcl-2 expression, and the 18 h that represented the period of induced Bcl-2 expression. Cultured ORNs were treated with a 10 μM odorant mixture for 6 and 18 h, respectively, and cells were subjected to the calcein assay. When ORN cultures were incubated in the presence of odorants, cell viability significantly increased over both time courses. We also tested the role of the PI3K/Akt pathway in the odorant stimulation-promoted ORN survival. The ORN cultures were treated in media containing LY294002 (50 μM), or were incubated with siRNA for Akt1 24 h prior to the odorant treatment to inhibit the PI3K/Akt pathway. Inhibition of both PI3K and Akt1 significantly decreased the odorant stimulation-induced ORN survival at 18 h ([Figs. 3C and 3D](#f3-molce-38-6-535){ref-type="fig"}). Interestingly, at 6 hours, inhibition of either PI3K or Akt1 did not seem to affect the viability of ORNs ([Figs. 3A and 3B](#f3-molce-38-6-535){ref-type="fig"}). To confirm the correlation between Akt activation and late expression of Bcl-2, we showed that the survival effect of Akt activated by odorant exposure was only involved at the later time point (\> 18 h) as opposed to the earlier time point (\< 6 h). This result is well correlated with delayed Bcl-2 expression (\< 12 h) after odorant stimulation. Our data suggest that odorant stimulation affects long-term ORN survival *via* PI3K/Akt dependent pathways, but is not involved in short-term ORN survival.

DISCUSSION
==========

Our study demonstrated that olfactory sensory stimulation, which induced neuronal activation, promoted activation of the PI3K/Akt pathway, subsequent expression of Bcl-2, and long-term ORN survival. Although we observed a time difference between the activation of the PI3K/Akt pathway and the increased expression of Bcl-2, we demonstrated that these two events were tightly connected. The results of our experiments suggested that olfactory activity activated the PI3K/Akt pathway to induce Bcl-2 expression and promote long term ORN survival.

The results of previous studies have suggested that sensory stimuli induce survival of sensory neurons though increased anti-apoptotic Bcl-2 expression ([@b13-molce-38-6-535]). In the current study, we confirmed Bcl-2 expression in ORNs following odorant stimulation *in vivo* and *in vitro*, and our results implied that the Bcl-2-related survival effect of ORNs mediated by odorant stimulation may occur regardless of the retrograde survival signals derived from the olfactory bulb (OB). Our *in situ* hybridization results suggested that *bcl-2* mRNA expression increased in the *omp* mRNA-expressing layer where mature ORNs reside in the OE. Because we were able to demonstrate Bcl-2 expression in dissociated ORN cultures more than 12 h after exposure to odorants, we concluded that odorant stimulation directly promoted Bcl-2 induction. Collectively, this delayed response in Bcl-2 expression following odorant stimulation in the ORNs in the mature OE implied that Bcl-2 induction may affect the long-term survival of ORNs in the OE. Therefore, we precluded the possibility that the long-term effects of odorant stimulation were mediated by the effects of activities derived from the OB. Importantly, we observed *bcl-2* mRNA up-regulation even in the sustentacular cells upon odorant stimulation, implying that odorant stimulation may affect *bcl-2* mRNA expression in the sustentacular cells, most likely in an indirect manner.

One of the main areas of interests in the present study was the activation of the PI3K/Akt pathway upon odorant stimulation, and the connection between this activation and the anti-apoptotic effects that followed Bcl-2 expression. In previous studies, the PI signaling controlled by the PI3K/Akt pathway showed important functions in ORN signaling by regulating the activity of ion channels and transporters ([@b20-molce-38-6-535]; [@b24-molce-38-6-535]; [@b25-molce-38-6-535]). In the current study, we showed Akt activation in a time-dependent manner following odorant exposure in cultured ORNs. The activated PI3K/Akt pathway may exert its influence on the regulation of various neuronal events, synaptic plasticity, and neurite outgrowth, through bio-synthesis ([@b2-molce-38-6-535]; [@b8-molce-38-6-535]; [@b10-molce-38-6-535]) and the activation of translation machinery, which induces expression of related downstream effectors predominantly involved in cell survival through the regulation of pro-apoptotic/anti-apoptotic proteins ([@b9-molce-38-6-535]; [@b26-molce-38-6-535]). Compared to Bcl-2 expression, Akt activation was induced at an earlier time point (1--3 h) following odorant exposure. Despite this discrepancy in the time courses of PI3K/Akt pathway activation and Bcl-2 induction, we demonstrated a close relationship between Bcl-2 expression and the PI3K/Akt signal pathway in ORNs, as Bcl-2 expression was completely blocked by pharmacological inhibition of PI3K and translational blockage of Akt1. Additionally, cell viability was well correlated with activation of the PI3K/Akt pathway and Bcl-2 expression. There may be no survival effect derived from activation of the PI3K/Akt pathway at earlier time points; however, increased ORN survival at the later time points following odorant exposure may have been attributable to activation of the PI3K/Akt pathway and subsequent expression of Bcl-2. Our results indicated that the PI3K/Akt pathway was necessary to induce delayed Bcl-2 expression (\< 12 h), likely dependent on gene expression triggered by activation of transcription factors which can be induced by odorant stimulation ([@b27-molce-38-6-535]).

Although these observations emphasize the importance of neuronal activation in sensory neuronal survival, the entirety of the mechanisms involved remain to be elucidated. The results of the current study revealed important aspects of these complex mechanisms. Olfactory sensory stimulation simultaneously promoted ORNs survival as a long-term cellular response through the intrinsic mechanisms of sensory neurons. Among the several neuroprotective signaling pathways mediated by neural activation, odorant-induced activation of the PI3K/Akt pathway was found to be responsible for promoting sensory neural survival associated with the expression of Bcl-2 by intrinsic mechanisms.
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![(A) *In situ* hybridization of *bcl-2* mRNA in mouse OE. *bcl-2* mRNA expression was visualized in the presence (OPEN) or absence (CLOSED) of odorant stimuli (1 mM) for 6 h. *omp* (an olfactory marker protein) mRNA was used as a control. Scale bars = 100 μm. (B) Northern blot of *bcl-2* mRNA and *gapdh* mRNA in ORN cultures. ORNs were exposed to 10 μM odorants for 6 h. (C) Immunoblot of Bcl-2, NST (β-tubulin III), and GAPDH in ORN cultures. Cells were treated with 10 μM odorants and sampled at a specific time (0, 1.5, 3, 6, 12, or 18 h). Results from the quantitative analysis of Bcl-2 expression induced by odorants from three independent experiments are summarized on the right. Quantification of each protein expression level was measured by stereological analysis using the ImageJ program, and compared to GAPDH expression. All data are presented as mean ± SEM. One-way analysis of variance (ANOVA), followed by Dunnett's post hoc test, was performed. \*P \< 0.05 denotes statistical significance.](molce-38-6-535f1){#f1-molce-38-6-535}

![(A) Analysis of PI3K/Akt pathway activation by odorants. ORNs were treated with 10 μM odorants and sampled at a specific time (0, 0.5, 1, 1.5, 2, 3, 4, or 6 h). Activation of Akt was measured using antibodies against phospho-Akt (pAkt) and total Akt (Akt). Quantification of protein expression levels was determined by stereological analysis using the ImageJ analysis program. Equal loading of samples was confirmed by monitoring the total Akt protein level. (B) Pharmacological blocking of Akt activation. ORNs were incubated in 50 μM LY294002, a PI3K inhibitor. Akt activation was clearly blocked by LY294002. Immunoblots for Bcl-2 and GAPDH in the presence of 50 μM LY294002 at specific times (0, 6, 12, and 18 h) were visualized. Results of the quantitative analysis of Bcl-2 expression by odorants in the presence or absence of LY294002 for PI3K were summarized. (C) Translational blocking of Akt activation. ORNs were incubated with siRNA for Akt1 for 18 h. Akt activation was clearly blocked by incubation with siRNA. Immunoblots for Bcl-2 and GAPDH after incubation with siRNA for Akt1 at specific times (0, 6, 12, and 18 h) were visualized. Results of the quantitative analysis of Bcl-2 expression by odorants after incubation with siRNA for Akt1 were summarized. All data are presented as mean ± SEM. One-way ANOVA, followed by Dunnett's post hoc test, was performed. \*P \< 0.05 and \*\*P \< 0.01 denote statistical significance.](molce-38-6-535f2){#f2-molce-38-6-535}

![(A, B) Neuroprotective effects of Akt activation by odorant stimulation in the early stage. In the presence of 10 μM odorants, ORNs were co-incubated for 6 h in the presence or absence of (A) 50 μM LY294002 or (B) siRNA for Akt1, respectively. (C, D) Neuroprotective effects of Akt activation by odorant stimulation in the late stage. In the presence of 10 μM odorants, ORNs were co-incubated for 18 h in the presence or absence of (C) 50 μM LY294002 or (D) siRNA for Akt1, respectively. Cell viability was assessed by the calcein assay. Data are expressed as percent of value in untreated control cultures (serum free condition). Data are presented as means ± SEM from three independent experiments. One-way ANOVA, followed by Dunnett's post hoc test, was performed. \*\*P \< 0.01 and \*\*\*P \< 0.001 denote statistical significance.](molce-38-6-535f3){#f3-molce-38-6-535}
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